The board of directors at Palleon Pharmaceuticals has a history of experience in the field of chemistry and molecular biology from professorships at notable institutions such as Stanford University and the University of California, Berkeley. In addition, many members have experience as independent board members for other companies in the biotech industry such as Theravance Biopharma US, Inc. and Karyopharm Therapeutics Inc. Members of the board also come from diverse educational backgrounds, including economics from the Massachusetts Institute of Technology and biochemistry from Columbia University.
View all